Outside the black box: Re-assessing pediatric antidepressant prescription

Journal of the Canadian Academy of Child and Adolescent Psychiatry

Volumn 22, Issue 3, 2013, Pages 240-246

  Sparks, Jacqueline A ^a   Duncan, Barry L ^b  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b Heart and Soul of Change Project   (United States)

Author keywords

Adolescents; Antidepressants; Black box; Children; SSRIs; Suicide

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CHILD BEHAVIOR; CHILD SAFETY; DRUG APPROVAL; DRUG CONTROL; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE AVAILABILITY; HUMAN; INCIDENCE; PRESCRIPTION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SUICIDE;

EID: 84881596453     PISSN: 17198429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Adegbite-Adeniyi, C., Gron, B., Rowles, B. M., Demeter, C. A., & Findling, R. L. (2012). An update on antidepressant use and suicidality in pediatric depression. Expert Opinion Pharmacotherapy, 13(15), 2119-2130.
2. Brent, D., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M.,... Zelazny, J., (2008). Switching to another SSRI or to venlafaxine with or without cognitive behavioural therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. JAMA, 299, 901-913.
3. Brent, D., Greenhill, M., Comptom, S., Emslie, G., Wells, K., Walkup, J.,... Turner, B., (2009). The treatment of adolescent suicide attempters study (TASA): Predictors of suicidal events in an open treatment trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 987-996.
4. Bridge J. A., lyengar S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H.A.,... Brent, D. A. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA, 297(15), 1683-1696.
5. Chai, G., Governale, L., McMahon, A. W., Trinidad, J. P., Staffa, J., & Murphy, D. (2012). Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics, 130(1), 22-32.
6. Chen, S-Y, & Toh, S. (2011). National trends in prescribing antidepressants before and after an FDA advisory on suicidality risk in youth. Psychiatric Services, 62, 727-733.
7. Cheung, A. H., Zuckerbrot, R. A., Jensen, P. S., Ghalib, K., Laraque, D., & Stein, R. E. K. (2007). Guidelines for adolescent depression in primary care (GLAD-PC): II. Treatment and ongoing management. Pediatrics, 120, e1313.
8. Delate, T., Gelenberg, A. J., Simmons, V. A., & Motheral, B. R. (2004). Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Psychiatric Services, 55(4), 387-391.
9. Emslie, G. J., Heiligenstein, J. H., Wagner, K. D., Hoog, S. L., Ernest, D. E., Brown, E.,... Jacobson, J. G., (2002). Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41(10), 1205-1215.
10. Emslie, G. J., Mayes, T., Porta, G., Vitiello, B., Clarke, G., Wagner, K.G.,... Brent, D. (2010). Treatment resistant depression in adolescents (TORDIA): Week 24 outcomes. American Journal of Psychiatry, 167, 782-791.
11. Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., & Rintelman, J. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54(11), 1031-1037.
12. FDA (2000), October 10. Statistical review. Retrieved from: www.antidepressantsfacts.com/doctor-Emslie-3.pdf.
13. FDA (2004, October 15). FDA Public Health Advisory: Suicidality in children and adolescents being treated with antidepressant medications. Retrieved from: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm161679.htm.
14. Gibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., Erkens, J.A.,... Mann, J. J. (2007). Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry, 164, 1356-1363.
15. Gibbons, R. D., Hur, K., Brown, C. H., Davis, J. M., & Mann, J. (2012). Benefits from antidepressants: Synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Archives of General Psychiatry, 69(6), 572-579.
16. Gibbons, R. D., Brown, C. H., Hur, K., Davis, J. M., & Mann, J. (2012). Suicidal thoughts and behaviour with antidepressant treatment: Reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Archives of General Psychiatry, 69(6), 580-587.
17. Gu, Q., Dillon, C. F., & Burt, V. L. (2010). Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008. NCHS Data Brief, 42, September, 2010. Retrieved from http://www.cdc.gov/nchs/data/databriefs/db42.htm.
18. Hammad, T. (2004). Relationship between psychotropic drugs and pediatric suicidality, 1-131 [http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf]. FDA Accessed June 2005.
19. Hammad, T. A., Laughren, T., & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332-339.
20. Jureidini, J. N., Doecke, C. J., Mansfield, P. R., Haby, M. M., Menkes, D. B., & Tonkin, A. I. (2004). Efficacy and safety of antidepressants for children and adolescents. British Medical Journal, 328, 879-883.
21. Jureidini, J. (2009). How do we safely treat depression in children, adolescents, and young adults? Drug Safety, 32(4), 275-282.
22. Kratochvil, C. J., Newcorn, J. H., Arnold, E., Duesenberg, D., Emslie, G. J., Quintana, H.,... Biederman, J., (2005). Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. Journal of the American Academy of Child & Adolescent Psychiatry, 44(9), 915-924.
23. Laughren T. (2006, December 13). Memorandum: Overview for the December 13 meeting of Psychopharmacologic Drugs Advisory Committee. Food and Drug Administration; 2006. Retrieved from: www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-fda.pdf.
24. Libby, A. M., Brent, D. A., Morrato, E. H., Orton, H. D., Allen, R., & Valuck, R. J. (2007). Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. The American Journal of Psychiatry, 164(6), 884-891.
25. Lowry, F. (2012, February 21). No link between antidepressants and suicide in kids: Study calls FDA black box warning into question. Retrieved from: http://www.medscape.com/viewarticle/758917?src=e mailthis.
26. March, J., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J.,... Severe, J., (2004) Fluoxetine, cognitive-behavioural therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA, 292, 807-820.
27. March, J. S., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J.,... Severe, J., (2007) The Treatment for Adolescents With Depression Study (TADS): Long-term effectiveness and safety outcomes. Archives of General Psychiatry, 64, 1132-1143.
28. Mosholder, A. D., & Willy, M. (2006). Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active treatment: A meta-analysis. Journal of Child & Adolescent Psychopharmacology, 16(1-2), 25-32.
29. Nemeroff, C. B., Kalali, A., Keller, M. B., Charney, D. S., Lenderts, S. E., Cascade, E.F.,... Schatzberg, A. F. (2007). Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Archives of General Psychiatry, 64(4), 466-472.
30. Offidan, E., Fava, G. A., Tomba, E., & Baldessarini, R. J. (2013). Excessive mood elevation and behavioural activation with antidepressant treatment of juvenile depressive and anxiety disorders: A systematic review. Psychotherapy and Psychosomatics, 82(3), 132-141.
31. Olfson, M., Marcus, S. C., & Druss, B. G. (2008). Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Archives of General Psychiatry, 65(1), 94-101.
32. Olfson, M., Marcus, S. C., & Shaffer, D. (2006). Antidepressant drug therapy and suicide in severely depressed children and adults. Archives of General Psychiatry, 63, 865-872.
33. Pamer, C. A., Hammad, T. A., Wu, Y. T., Kaplan, S., Rochester, G., Governale, L., & Mosholder, A. D. (2010). Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions. Pharmacoepidemiology and Drug Safety, 19(2), 158-174.
34. Posner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007). Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. American Journal of Psychiatry, 164, 1035-1043.
35. Poznanski, E. & Mokros, H. (1996). Children's Depression Rating Scale - Revised (CDRS-R) Los Angeles, CA: WPS.
36. Roan, S. (2012, February 6). Study questions antidepressant link to suicide in kids. Retrieved from: http://articles.latimes.com/2012/ feb/06/news/la-heb-antidepressants-kids-20120206.
37. Spiegel, A. (2012, February 7). A fresh look at antidepressants finds low risk of youth suicide. SHOTS: NPR Health Blog. Retrieved from: http://www.npr.org/blogs/health/2012/02/06/146481573/a-fresh-lookat-antidepressants-finds-low-risk-of-youth-suicide.
38. Spielmans, G. I., Jureidini, J., Healy, D., & Purssey, R. (2013). Inappropriate data and measures lead to questionable conclusions. JAMA Psychiatry, 70(1), 121-122.
39. Tsapakis M. E., Soldani F., Tondo L., & Baldessarini, R. J. (2008). Efficacy of antidepressants in juvenile depression: Meta-analysis. British Journal of Psychiatry, 193, 10-17.
40. Vitiello, B., Silva, S. G., Rohde, P., Kratochvil, C. J., Kennard, B. D., Reinecke, M.A.,... March, J. S. (2009). Suicidal events in the Treatment for Adolescents With Depression Study (TADS). Journal of Clinical Psychiatry, 70, 741-747.
41. Vitiello, B., Brent, D., Greenhill, L., Emslie, G., Wells, K., Walkup, J.,... Zelazny, J., (2009). Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) study. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 997-1004.
42. Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet, 363, 1341-1345.
43. Wijlaars, L. P. M. M., Nazareth, I., & Petersen, I. (2012). Trends in depression and antidepressant prescribing in children and adolescents: A cohort study in the Health Improvement Network (THIN). PLoS ONE, 7(3): e33181.
44. Zito, J. (2002). Rising prevalence of antidepressants among US youths. Pediatrics, 109(5), 721-727.